A Retrospective European Collaborative Study to Examine Off-Label Biological Therapy Use for Relapsing/Refractory Eosinophilic Granulomatosis with Polyangiitis (Churg–Strauss)
Latest Information Update: 10 Feb 2020
At a glance
- Drugs Mepolizumab (Primary) ; Omalizumab (Primary) ; Rituximab (Primary)
- Indications Churg-Strauss syndrome
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 10 Feb 2020 New trial record